Tue, August 16, 2022

Keay Nakae Maintained (SONN) at Strong Buy on, Aug 16th, 2022

Keay Nakae of Chardan Capital, Maintained "Sonnet BioTherapeutics Holdings, Inc." (SONN) at Strong Buy on, Aug 16th, 2022.

Keay, nor any peers, have made any analyst calls on SONN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30